Terms: = Kidney tumors AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677
30 results:
1. EMX2 inhibits clear cell renal cell carcinoma progress via modulating Akt/foxo3a pathway.
Zhou X; Dong S; Zhou Y; He Z; Zhang Z; Liao L; Zou B; Zheng X; Peng K; Duan X
Mol Carcinog; 2024 May; 63(5):951-961. PubMed ID: 38362840
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA LBX2-AS1 promotes proliferation and migratory capacity of clear cell renal cell carcinoma through mitophagy.
Wang B; Wei Y; Han T; Ji P; Miao H; Wu X; Qian J; Shao P
Eur J Med Res; 2024 Feb; 29(1):103. PubMed ID: 38326905
[TBL] [Abstract] [Full Text] [Related]
3. Anti-cancer activity of microbubble conjugated with Sorafenib containing liposome and IL4R-targeting peptide in kidney cancer cells.
Lee J; Park SH
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):266-271. PubMed ID: 38279420
[TBL] [Abstract] [Full Text] [Related]
4. AIM2 promotes renal cell carcinoma progression and sunitinib resistance through foxo3a-ACSL4 axis-regulated ferroptosis.
Wang Q; Gao S; Shou Y; Jia Y; Wei Z; Liu Y; Shi J; Miao D; Miao Q; Zhao C; Liu C; Yang H; Xu T; Zhang X
Int J Biol Sci; 2023; 19(4):1266-1283. PubMed ID: 36923928
[TBL] [Abstract] [Full Text] [Related]
5. Sodium selenite inhibits cervical cancer growth via ROS mediated AMPK/foxo3a /GADD45a axis.
Qi L; Wang Y; Su S; Wang M; Jablonska E; Jia Y; Wang R; Hao S; Feng C; Li G; Jiang M; Du L; Sun H; Li Q; Wang T
Chem Biol Interact; 2022 Nov; 367():110171. PubMed ID: 36108716
[TBL] [Abstract] [Full Text] [Related]
6. Aurora-A/foxo3A/SKP2 axis promotes tumor progression in clear cell renal cell carcinoma and dual-targeting Aurora-A/SKP2 shows synthetic lethality.
Li P; Chen T; Kuang P; Liu F; Li Z; Liu F; Wang Y; Zhang W; Cai X
Cell Death Dis; 2022 Jul; 13(7):606. PubMed ID: 35831273
[TBL] [Abstract] [Full Text] [Related]
7. foxo3a‑modulated DEPDC1 promotes malignant progression of nephroblastoma via the Wnt/β‑catenin signaling pathway.
Geng G; Li Q; Guo X; Ni Q; Xu Y; Ma Z; Wang Y; Ming M
Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35795985
[TBL] [Abstract] [Full Text] [Related]
8. Acetylshikonin, A Novel CYP2J2 Inhibitor, Induces Apoptosis in RCC Cells via foxo3 Activation and ROS Elevation.
Lim HM; Lee J; Yu SH; Nam MJ; Cha HS; Park K; Yang YH; Jang KY; Park SH
Oxid Med Cell Longev; 2022; 2022():9139338. PubMed ID: 35308176
[TBL] [Abstract] [Full Text] [Related]
9. Association of
Yu C; Hodge AM; Wong EM; Joo JE; Makalic E; Schmidt D; Buchanan DD; Hopper JL; Giles GG; Southey MC; Dugué PA
Cells; 2021 Dec; 10(12):. PubMed ID: 34943892
[TBL] [Abstract] [Full Text] [Related]
10. System analysis of
Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
[TBL] [Abstract] [Full Text] [Related]
11. Broussochalcone A Induces Apoptosis in Human Renal Cancer Cells via ROS Level Elevation and Activation of foxo3 Signaling Pathway.
Lee HK; Cha HS; Nam MJ; Park K; Yang YH; Lee J; Park SH
Oxid Med Cell Longev; 2021; 2021():2800706. PubMed ID: 34745413
[TBL] [Abstract] [Full Text] [Related]
12. foxo3a inhibits nephroblastoma cell proliferation, migration and invasion, and induces apoptosis through downregulating the Wnt/β‑catenin signaling pathway.
Qian C; Liu Q
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34515328
[TBL] [Abstract] [Full Text] [Related]
13. Hypoxia-induced microRNA-155 overexpression in extracellular vesicles promotes renal cell carcinoma progression by targeting
Meng L; Xing Z; Guo Z; Qiu Y; Liu Z
Aging (Albany NY); 2021 Mar; 13(7):9613-9626. PubMed ID: 33742606
[TBL] [Abstract] [Full Text] [Related]
14. Allogeneic red blood cell transfusion is an independent risk factor for 1-year mortality in elderly patients undergoing femoral neck fracture surgery: Retrospective study.
Shin HJ; Kim JH; Han SB; Park JH; Jang WY
Medicine (Baltimore); 2020 Aug; 99(35):e21897. PubMed ID: 32871921
[TBL] [Abstract] [Full Text] [Related]
15. Phosphofructokinase-M inhibits cell growth via modulating the foxo3 pathway in renal cell carcinoma cells.
Chen Y; Yu Q; Duan X; Wu W; Zeng G
Biochem Biophys Res Commun; 2020 Sep; 530(1):67-74. PubMed ID: 32828317
[TBL] [Abstract] [Full Text] [Related]
16. Oxidative Stress and Cancer Development: Are Noncoding RNAs the Missing Links?
D'Souza LC; Mishra S; Chakraborty A; Shekher A; Sharma A; Gupta SC
Antioxid Redox Signal; 2020 Dec; 33(17):1209-1229. PubMed ID: 31891666
[No Abstract] [Full Text] [Related]
17. A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/foxo3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma.
Zhai W; Zhu R; Ma J; Gong D; Zhang H; Zhang J; Chen Y; Huang Y; Zheng J; Xue W
Mol Cancer; 2019 Apr; 18(1):81. PubMed ID: 30953521
[TBL] [Abstract] [Full Text] [Related]
18. miR‑122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3.
Nie W; Ni D; Ma X; Zhang Y; Gao Y; Peng C; Zhang X
Int J Oncol; 2019 Feb; 54(2):559-571. PubMed ID: 30483771
[TBL] [Abstract] [Full Text] [Related]
19. The Dual Specificity Role of Transcription Factor FOXO in Type 2-diabetes and Cancer.
Fatima K; Mathew S; Faheem M; Mehmood T; Yassine HM; Al Thani AA; Abdel-Hafiz H; Al Ghamdy K; Qadri I
Curr Pharm Des; 2018; 24(24):2839-2848. PubMed ID: 30205794
[TBL] [Abstract] [Full Text] [Related]
20. 16-Hydroxycleroda-3, 13-dien-15, 16-olide inhibits the proliferation and induces mitochondrial-dependent apoptosis through Akt, mTOR, and MEK-ERK pathways in human renal carcinoma cells.
Liu C; Lee WC; Huang BM; Chia YC; Chen YC; Chen YC
Phytomedicine; 2017 Dec; 36():95-107. PubMed ID: 29157834
[TBL] [Abstract] [Full Text] [Related]
[Next]
